Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
8,279,384
-
Share change
-
+483,540
-
Total reported value
-
$53,807,633
-
Price per share
-
$6.50
-
Number of holders
-
34
-
Value change
-
+$2,350,102
-
Number of buys
-
8
-
Number of sells
-
16
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q2 2019
As of 30 Jun 2019,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,279,384 shares.
The largest 10 holders included
683 Capital Management, LLC, Ibex Investors LLC, DISCIPLINED GROWTH INVESTORS INC /MN, Migdal Insurance & Financial Holdings Ltd., Creative Planning, Kepos Capital LP, FMR LLC, MORGAN STANLEY, Candriam Luxembourg S.C.A., and MILLENNIUM MANAGEMENT LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.